Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may become altered, leading to a worsening of symptoms.
As in rheumatoid arthritis ... Low disease activity is an achievable target in psoriatic arthritis. It is not sufficient to measure only the articular involvement in this complex heterogeneous ...
The emergence of new treatments and therapeutic approaches for psoriatic arthritis is improving physicians’ ability to treat a complicated, multifaceted disease. This episode details how ...
To that end, the company has reported positive results for two phase 3 trials of Sotyktu in adult patients who have psoriatic arthritis (PsA). Without revealing figures, BMS said that the POETYK ...
The global remicade biosimilar market is projected to expand significantly between 2025 and 2035, with a market size growing from USD 2.32 billion in 2025 to USD 4.01 billion in 2035, at a robust ...